Loading…
A novel anti-CD19 chimeric T cell therapy platform ET019002 was safe and effective in inducing CR in blast crisis of CML: A case study
He, Pengcheng, Liu, Hong, Liu, Haibo, Li, Qijing, Luo, Mina, Feng, Hui, Ye, Kai, Nejadnik, Bijan, Shi, Bingyin, Liu, Cheng
Published in Journal of clinical oncology (20.05.2019)
Published in Journal of clinical oncology (20.05.2019)
Get full text
Journal Article
Loading…
HIF2-α Expression in CML Patients Receiving Hydroxyurea Prior to Imatinib That Achieved Major Molecular Response (MMR) versus in Those Not Achieving MMR
Rinaldi, Ikhwan, Mauludi, Radinal, Jusman, Sri, Sinto, Robert, Harimurti, Kuntjoro
Published in Journal of blood medicine (01.01.2024)
Published in Journal of blood medicine (01.01.2024)
Get full text
Journal Article
Loading…
Bosutinib in the Real-Life Treatment of Chronic Phase Chronic Myeloid Leukemia (CML) Patients Aged > 65 Years Resistant/Intolerant to Frontline Tyrosine-Kynase Inhibitors
Latagliata, Roberto, Attolico, Imma, Trawinska, Malgorzata Monika, Capodanno, Isabella, Annunziata, Mario, Elena, Chiara, Luciano, Luigiana, Crugnola, Monica, Bergamaschi, Micaela, Bonifacio, Massimiliano, Baratè, Claudia, Mauro, Endri, Binotto, Gianni, Sgherza, Nicola, Aguzzi, Chiara, Monteleone, Barbara, Sorà, Federica, Caocci, Giovanni, Luzi, Debora, Mariggiò, Elena, Scaffidi, Luigi, Cattaneo, Daniele, Gozzini, Antonella, Di veroli, Ambra, Galimberti, Sara, Iurlo, Alessandra, Breccia, Massimo, Specchia, Giorgina
Published in Blood (13.11.2019)
Published in Blood (13.11.2019)
Get full text
Journal Article
Loading…
Switch to Subsequent Line of Treatment in Children and Adolescents with Chronic Myeloid Leukemia (CML) Treated with Imatinib: Experience of the International Registry for Chronic Myeloid Leukemia in Children and Adolescents (I-CML-Ped Study)
Millot, Frédéric, Guilhot, Joelle, Suttorp, Meinolf, Meunier, Anne Sophie, Adalet Meral, Gunes, Sedlacek, Petr, de Bont, Eveline, Li, Chi Kong, Kalwak, Krzysztof, Lausen, Birgitte, Culic, Srdjana, De Moerloose, Barbara, Biondi, Andrea, Baruchel, Andre
Published in Blood (03.12.2015)
Published in Blood (03.12.2015)
Get full text
Journal Article
Loading…
Disposition of asciminib, a potent BCR-ABL1 tyrosine kinase inhibitor, in healthy male subjects
Tran, Phi, Hanna, Imad, Eggimann, Fabian Kurt, Schoepfer, Joseph, Ray, Tapan, Zhu, Bing, Wang, Lai, Priess, Petra, Tian, Xianbin, Hourcade-Potelleret, Florence, Einolf, Heidi J.
Published in Xenobiotica (01.02.2020)
Published in Xenobiotica (01.02.2020)
Get full text
Journal Article
Loading…
Total plasma Nε-(carboxymethyl)lysine and sRAGE levels are inversely associated with a number of metabolic syndrome risk factors in non-diabetic young-to-middle-aged medication-free subjects
Šebeková, Katarína, Krivošíková, Zora, Gajdoš, Martin
Published in Clinical chemistry and laboratory medicine (01.01.2014)
Published in Clinical chemistry and laboratory medicine (01.01.2014)
Get full text
Journal Article
Loading…
Impact of Additional Chromosomal Abnormalities in Philadelphia-Positive Clone on Prognosis of CML Patients Treated with Tyrosine Kinase Inhibitors
Liu, Bingcheng, Wang, Ying, Wei, Hui, Liu, Kaiqi, Lin, Dong, Zhou, Chunlin, Mi, Yingchang, Wang, Jianxiang
Published in Blood (02.12.2016)
Published in Blood (02.12.2016)
Get full text
Journal Article
Loading…
ABL Tyrosine Kinase Inhibitors (TKIs) Are Associated with Increased Rho-Associated Kinase (ROCK) Activity That May Contribute to Vascular Toxicity in Patients with Chronic Myeloid Leukemia (CML)
Osman, Afaf, Yu, Brian, Glavin, Nancy, Polonsky, Tamar S., Liao, James K., Larson, Richard A.
Published in Blood (29.11.2018)
Published in Blood (29.11.2018)
Get full text
Journal Article
Loading…
Association between carotid diameter and the advanced glycation endproduct Nε-Carboxymethyllysine (CML)
Baumann, Marcus, Richart, Tom, Sollinger, Daniel, Pelisek, Jaroslav, Roos, Marcel, Kouznetsova, Tatiana, Eckstein, Hans-Henning, Heemann, Uwe, Staessen, Jan
Published in Cardiovascular diabetology (06.08.2009)
Published in Cardiovascular diabetology (06.08.2009)
Get full text
Journal Article
Loading…
Phase 1 Trial of K0706, a Novel Oral BCR-ABL1 Tyrosine Kinase Inhibitor (TKI): In Patients with Chronic Myelogenous Leukemia (CML) and Phildelphia Positive Acute Lymphoblastic Leukemia (Ph+ ALL) Failing ≥ 3 Prior TKI Therapies: Initial Safety and Efficacy
Cortes, Jorge E., Kim, Dong-Wook, Nicolini, Franck E, Saikia, Tapan, Charbonnier, Aude, Apperley, Jane F., Rathnam, Krishna, Deininger, Michael W., De Lavallade, Hugues, Khattry, Navin, Whiteley, Andrew, Mauro, Michael J., Verhoef, Gregor, Gambacorti-Passerini, Carlo, Lucchesi, Alessandro, Apte, Shashikant, Nikki, Granacher, Yao, Siu-Long, Kothekar, Mudgal, Sreenivasan, Jayasree, HV, Bimba, Chimote, Geetanjali
Published in Blood (13.11.2019)
Published in Blood (13.11.2019)
Get full text
Journal Article
Loading…
HIF2-[alpha] Expression in CML Patients Receiving Hydroxyurea Prior to Imatinib That Achieved Major Molecular Response versus in Those Not Achieving MMR
Rinaldi, Ikhwan, Mauludi, Radinal, Jusman, Sri Widia, Sinto, Robert, Harimu
Published in Journal of blood medicine (29.02.2024)
Published in Journal of blood medicine (29.02.2024)
Get full text
Journal Article
Loading…
Rare Case of Alternative Splicing Form Caused By L248V Mutation in CML Patient
Butylin, Pavel, Matyuhina, Natalia, Siordia, Nadia, Lomaya, Elza, Zaritskey, Andrey
Published in Blood (03.12.2015)
Published in Blood (03.12.2015)
Get full text
Journal Article
Loading…
Second-Line Bosutinib in Patients with Chronic Phase Chronic Myeloid Leukemia (CP CML) Resistant or Intolerant to Prior Imatinib: An 8-Year Update
Brümmendorf, Tim H., Gambacorti-Passerini, Carlo, Kim, Dong-Wook, Goh, Yeow Tee, Dyagil, Iryna, Pagnano, Katia B, Bátai, Árpád, Turkina, Anna G, Aguiar, Jean M., Leip, Eric, Cortes, Jorge E.
Published in Blood (08.12.2017)
Published in Blood (08.12.2017)
Get full text
Journal Article
Loading…
Cooking methods affect advanced glycation end products and lipid profiles: A randomized cross-over study in healthy subjects
Wellens, Judith, Vissers, Eva, Dumoulin, Anaïs, Hoekx, Sien, Vanderstappen, Julie, Verbeke, Joke, Vangoitsenhoven, Roman, Derrien, Muriel, Verstockt, Bram, Ferrante, Marc, Matthys, Christophe, Raes, Jeroen, Verbeke, Kristin, Vermeire, Séverine, Sabino, João
Published in Cell reports. Medicine (20.05.2025)
Published in Cell reports. Medicine (20.05.2025)
Get full text
Journal Article
Loading…
Nilotinib Deregulates Cell Cycle Checkpoints, ABC Transporters Genes and JAK-STAT Signaling Pathway of CD34+/Lin- Cells in Chronic-Phase Chronic Myeloid Leukemia (CP-CML) Patients after 12 Months of Treatment
Trojani, Alessandra, Pungolino, Ester, Rossi, Giuseppe, D'adda, Mariella, Lodola, Milena, Dal Molin, Alessandra, Baruzzo, Giacomo, Perego, Alessandra, Turrini, Mauro, Elena, Chiara, Borin, Lorenza Maria, Iurlo, Alessandra, Malato, Simona, Spina, Francesco, Latargia, Maria Luisa, Spedini, Pierangelo, Artale, Salvatore, Anghilieri, Michela, Maria Cristina, Carraro, Bucelli, Cristina, De Canal, Gabriella, Morra, Enrica, Cairoli, Roberto
Published in Blood (29.11.2018)
Published in Blood (29.11.2018)
Get full text
Journal Article
Loading…
Loading…
Loading…
Critical Interferon-Response Genes Are Induced By JAK2V617F but Repressed By BCR-ABL, and They Are Responsible for the Differential Effects of Interferon in PV Vs. CML
Schubert, Claudia, Costa, Ivan G., Schemionek, Mirle, Feldberg, Kristina, Baumeister, Julian, Brümmendorf, Tim H., Koschmieder, Steffen, Chatain, Nicolas
Published in Blood (08.12.2017)
Published in Blood (08.12.2017)
Get full text
Journal Article
Loading…
Loading…
Advanced Glycation End-Products (AGEs) and Their Soluble Receptor (sRAGE) in Women Suffering from Systemic Lupus Erythematosus (SLE)
Nowak, Agnieszka, Przywara-Chowaniec, Brygida, Damasiewicz-Bodzek, Aleksandra, Blachut, Dominika, Nowalany-Kozielska, Ewa, Tyrpień-Golder, Krystyna
Published in Cells (Basel, Switzerland) (13.12.2021)
Published in Cells (Basel, Switzerland) (13.12.2021)
Get full text
Journal Article